Megan Mantica
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| VorAsidenib With Lomustine In Patients With rEcurrent IDH-mutaNT Glioma Harboring IDH1 and/or IDH2 Mutations (NCT07629089) | Megan Mantica | 2026-06-30 |
Track Megan Mantica automatically
Every clearance here is in the API, with alerts when new ones post.